Our infectious disease specialists provide consult services to Seattle Cancer Care Alliance (SCCA) patients. Clinical services are provided at both inpatient (University of Washington Medical Center) and outpatient settings (SCCA outpatient facility located on the Fred Hutch campus).
IDS faculty physicians pursue a team approach to providing exceptional patient care, working closely with hematologists and oncologists on individual treatment plans for patients. Our researcher physicians also oversee critical quality-improvement initiatives related to infectious diseases, including the development of standard practice guidelines and other clinical care guidelines in infection control and antibiotics management.
With a background in hematopoetic cell transplant, Bhattacharyya is applying that knowledge to working with patients with infectious disease issues while continuing to provide thorough and compassionate care.
Dr. Boeckh studies infections in the immunocompromised host, especially diagnosis, prevention and treatment of CMV, VZV, BK virus, adenovirus and respiratory virus infections.
Dr. Duke studies viral infections that affect immunocompromised patients, using mathematical modeling. She is currently working on models of CMV infection in allogeneic transplant patients and cure strategies for HIV.
Dr. Ford is interested in the care and treatment of infections in immunocompromised patients.
Dr. Fredricks' focus is on the use of molecular methods for the diagnosis of bacterial and fungal infections.
Dr. Geballe's focus is on the interactions between the cellular antiviral protein kinase R (PKR) and viral PKR antagonists expressed by human cytomegalovirus, and vaccinia virus.
Dr. Hill specializes in treating viral infections in immunocompromised cancer patients.
Dr. Liu focuses on improving patient outcomes through antimicrobial stewardship and outpatient parenteral antimicrobial therapy programs, by promoting appropriate use of antibiotics and optimizing transitions of care.
As a physician assistant, Mattson provided care with kindness and respect while having a thorough knowledge of the patient’s infectious disease issues.
Dr. McElrath's research centers on developing an HIV vaccine and investigates the complex relationships between HIV and the immune system.
Dr. Pergam's focus is in the area of CMV and gastrointestinal systems in transplant and cancer patients.
Dr. Phipps is interested in human herpesvirus-8 (HHV-8) virology and pathogenesis of Karposi sarcoma (KS), the most common HIV-associated malignancy worldwide.
Dr. Pottinger is interested in ways to improve the use of anti-infective medications for the complex and heterogeneous patient population in the field of Antimicrobial Stewardship.
Dr. Schiffer is interested in describing the quantitative and dynamic features of human pathogens and immune responses.
So enjoys working and providing care for people of all ages and backgrounds. She brings her molecular biology education as well as her bone marrow transplant service experience to provide care for her patients.
Dr. Wald is interested in epidemiology, natural history, therapy and prevention of HSV and other herpesvirus infections, including the interactions between HSV and HIV.